To announce the expected date of the board of directors meeting to approve the consolidated financial statements is 2025/2/21 for the fourth quarter of 2024
Announcement on behalf of major subsidiary,CHUANG YI BIOTECH CO.,LTD.,regarding acquisition of right-of-use asset from related party(Update of lease agreement)
Announcement on behalf of major subsidiary,CHUANG YI BIOTECH CO.,LTD.,regarding acquisition of right-of-use asset from related arty(renew lease agreement period)
Announcement on behalf of major subsidiary,TOP Biological Technology Company Limited regarding important resolutions of 2024 Special Shareholders' Meeting